Home » Trials » SLCTR/2024/022 » Protocols


Trials - SLCTR/2024/022

Protocol Change

Date

2025-03-11


Protocol

Protocol changed


Item Changed

Inclusion criteria


Previous Version

• Males and females age >=18 years • Current hospitalization or recently discharged with the primary diagnosis of heart failure • Heart failure signs and symptoms at the time of hospital admission • Imaging evidence of mildly reduced or preserved left ventricular ejection fraction (EF) (40% or higher) • Elevated N-terminal pro B-type natriuretic peptide (NTproBNP) >=1000 pg/mL or B-type natriuretic peptide (BNP) >=250 pg/mL for patients without atrial fibrillation (AF); or elevated NTproBNP >=2000 pg/mL or BNP >=500 pg/mL for patients with AF


Next Version

• Males and females age >=18 years • Current hospitalization or recently discharged with the primary diagnosis of heart failure • Heart failure signs and symptoms at the time of hospital admission • Imaging evidence of mildly reduced or preserved left ventricular ejection fraction (EF) (40% or higher) • Elevated N-terminal pro B-type natriuretic peptide (NTproBNP) >=500 pg/mL or B-type natriuretic peptide (BNP) >=125 pg/mL for patients without atrial fibrillation (AF); or elevated NTproBNP >=1500 pg/mL or BNP >=375 pg/mL for patients with AF